Reverse merged with Extruded Pharma in Jun 2024
AMC - Amur Minerals Corporation
LSE
->
Basic Materials
->
Other Industrial Metals & Mining
Road Town,
British Virgin Islands
Type: Equity
AMC price evolution
AMC
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $108.1 | $156 | $140.4 | $205.2 |
| Inventory | $39.5 | |||
| Total current assets | $789.1 | $1075.5 | $913 | $1203.1 |
| Long term investments | ||||
| Property, plant & equipment | $4836.3 | $4850.6 | $4963.8 | $5108.5 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $8324.1 | $8594.7 | $8538.7 | $9009.2 |
| Current liabilities | ||||
| Accounts payable | $247.7 | $301.1 | $250.2 | $320.5 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1578.9 | $1651.2 | $1503 | $1632.4 |
| Long term debt | $4097 | $4258.7 | $4566 | $4602.3 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $10009.4 | $10291.3 | $10569.7 | $10857.1 |
| Shareholders' equity | ||||
| Retained earnings | -$8211.2 | -$8190.5 | -$8157.7 | -$7994.2 |
| Other shareholder equity | -$102.2 | -$110.8 | -$113.6 | -$78.2 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.68 | $2.79 | ||
| Short term investments | ||||
| Net receivables | $205.2 | $167.6 | $0.11 | $0.01 |
| Inventory | $39.5 | $36.4 | $31.3 | $0.21 |
| Total current assets | $1203.1 | $902.1 | $31.24 | $3.15 |
| Long term investments | $5.25 | |||
| Property, plant & equipment | $5108.5 | $5528.6 | $6128.1 | $0.45 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $9009.2 | $9135.6 | $31.24 | $32.4 |
| Current liabilities | ||||
| Accounts payable | $320.5 | $330.5 | $0.97 | $0.31 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1632.4 | $1690.3 | $0.97 | $0.91 |
| Long term debt | $4621 | $5174.1 | $5471.5 | $5809 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $10857.1 | $11760.1 | $1.13 | $1.05 |
| Shareholders' equity | ||||
| Retained earnings | -$7994.2 | -$7597.6 | -$37.52 | -$36.48 |
| Other shareholder equity | -$78.2 | -$77.3 | -$17.1 | -$16.9 |
| Total shareholder equity | $30.11 | $31.35 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1348.8 | $1030.6 | $951.4 | $1104.4 |
| Cost of revenue | ||||
| Gross Profit | $877.7 | $688.4 | $649.1 | $769 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $805.8 | $735.7 | $757.6 | $812.2 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$1.1 | $0.7 | $1.8 | -$1.2 |
| Interest expense | -$7.2 | -$82.1 | -$90 | -$73.3 |
| Net income | ||||
| Net income | -$20.7 | -$32.8 | -$163.5 | -$182 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4812.6 | $3911.4 | ||
| Cost of revenue | ||||
| Gross Profit | $3206.2 | $2631.1 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1.79 | $3.08 | ||
| Total operating expenses | $3171.9 | $3018.2 | $1.79 | $3.09 |
| Operating income | -$1.79 | -$3.09 | ||
| Income from continuing operations | ||||
| EBIT | -$1.79 | -$3.09 | ||
| Income tax expense | $3.4 | $2.5 | ||
| Interest expense | -$318.3 | -$344.7 | -$0.01 | |
| Net income | ||||
| Net income | -$396.6 | -$973.6 | -$1.21 | -$2.67 |
| Income (for common shares) | -$1.21 | -$2.67 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$154 | -$93.5 | -$50 | -$180.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $72.1 | $227.3 | -$9 | $649.3 |
| Effect of exchange rate | $2 | -$3.7 | -$3.4 | $3 |
| Change in cash and equivalents | -$334.3 | -$92.8 | -$250.7 | $257 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | -$1.21 | -$2.67 | ||
| Operating activities | ||||
| Depreciation | $0.01 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$1.83 | -$2.2 | ||
| Investing activities | ||||
| Capital expenditures | -$0.43 | -$0.56 | ||
| Investments | ||||
| Total cash flows from investing | -$180.1 | -$224 | $6.04 | -$5.18 |
| Financing activities | ||||
| Dividends paid | -$0.7 | |||
| Sale and purchase of stock | ||||
| Net borrowings | -$0.11 | |||
| Total cash flows from financing | $649.3 | -$91.3 | $9.89 | |
| Effect of exchange rate | $3 | -$22.1 | -$0.31 | -$0.13 |
| Change in cash and equivalents | $257 | -$965.9 | $3.89 | $2.39 |
News
|
China, Russia float idea for nuclear power on the moon: 'want to upstage the United States'
Fox News via Yahoo News
7 Mar 2024
|
|
Amur Minerals (LON:AMC) shareholders have earned a 21% CAGR over the last five years
Simply Wall St. via Yahoo Finance
3 Jul 2023
|
|
Factbox: Companies sell their businesses in Russia
Reuters via Yahoo Finance
22 Jun 2022
|
|
How China and Russia forged a friendship after bridging decades-old differences
South China Morning Post via Yahoo Finance
23 Jan 2022
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 364.94M |
| Revenue | $4.44B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$399.00M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.09 |
|---|---|
| ROA | -4.63% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.50 |
| Quick ratio | N/A |